Correction to: Gut microbiota influence tumor development and Alter interactions with the human immune system

Ge, Yanshan; Wang, Xinhui; Guo, Yu; Yan, Junting; Abuduwaili, Aliya; Aximujiang, Kasimujiang; Yan, Jie; Wu, Minghua

doi:10.1186/s13046-021-02131-1

Cited by 4 publications

(2 citation statements)

References 1 publication

Supporting

Mentioning

Contrasting

Order By: Relevance

“…For example, Lee et al reported that analysis of bronchoalveolar lavage fluid from 20 lung cancer patients showed that the abundance of two bacteria (Firmicutes and TM7) and two genera were significantly higher in lung cancer patients than in the healthy population [ 34 , 35 ]. Moreover, TM7-3, Capnocytophaga , Sediminibacterium , and Microbacterium were also significantly enriched compared to controls [ 36 – 38 ] (Fig. 4 ).…”

Section: Lung and Gastrointestinal Microecology In The Pathogenesis A...mentioning

confidence: 94%

Association of lung-intestinal microecology and lung cancer therapy

et al. 2023

View full text Add to dashboard Cite

In recent years, the incidence of lung cancer is increasing. Lung cancer has become one of the most malignant tumors with the highest incidence in the world, which seriously affects people’s health. The most important cause of death of lung cancer is metastasis. Therefore, it is crucial to understand the mechanism of lung cancer progression and metastasis. This review article discusses the physiological functions, pathological states and disorders of the lung and intestine based on the concepts of traditional Chinese medicine (TCM), and analyzes the etiology and mechanisms of lung cancer formation from the perspective of TCM. From the theory of “the exterior and interior of the lung and gastrointestinal tract”, the theory of “the lung-intestinal axis” and the progression and metastasis of lung cancer, we proposed e “lung-gut co-treatment” therapy for lung cancer. This study provides ideas for studying the mechanism of lung cancer and the comprehensive alternative treatment for lung cancer patients.

show abstract

Section: Lung and Gastrointestinal Microecology In The Pathogenesis A...mentioning

confidence: 94%

Association of lung-intestinal microecology and lung cancer therapy

et al. 2023

View full text Add to dashboard Cite

show abstract

“…It was previously stated that the gut microbiota exhibited various effects on the differentiation mechanism and tumor development. While they influence the tumor response to immunotherapeutics[ 71 ], the existence of intra-tumoral bacteria is reported in many solid tumors, especially in breast cancer. It was demonstrated that the microbiome is particular for each kind of malignant tumor presenting distinct metabolic functions[ 72 ].…”

Section: Immunotherapy In Crcmentioning

confidence: 99%

Implication of gut microbiome in immunotherapy for colorectal cancer

Koustas¹,

Trifylli²,

Sarantis³

et al. 2022

WJGO

View full text Add to dashboard Cite

Colorectal cancer (CRC) constitutes the third most frequently reported malignancy in the male population and the second most common in women in the last two decades. Colon carcinogenesis is a complex, multifactorial event, resulting from genetic and epigenetic aberrations, the impact of environmental factors, as well as the disturbance of the gut microbial ecosystem. The relationship between the intestinal microbiome and carcinogenesis was relatively undervalued in the last decade. However, its remarkable effect on metabolic and immune functions on the host has been in the spotlight as of recent years. There is a strong relationship between gut microbiome dysbiosis, bowel pathogenicity and responsiveness to anti-cancer treatment; including immunotherapy. Modifications of bacteriome consistency are closely associated with the immunologic response to immunotherapeutic agents. This condition that implies the necessity of gut microbiome manipulation. Thus, creatingan optimal response for CRC patients to immunotherapeutic agents. In this paper, we will review the current literature observing how gut microbiota influence the response of immunotherapy on CRC patients.

show abstract